Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 15 posts of 894 posts found.

Pfizer’s leukaemia drug gets opposing regulatory decisions on either side of the Atlantic

August 18, 2017
Medical Communications, Sales and Marketing Besponsa, Cancer, FDA, NICE, Pfizer, leukaemia, pharma, pharmaceutical

Pfizer has received a bittersweet bout of news as it emerges that its drug Besponsa (inotuzumab ozogamicin) has received approval …

News

Pfizer’s major drug doubles sales but overall revenue falls

August 1, 2017
Research and Development, Sales and Marketing Bavencio, Pfizer, biotech, drugs, pharma, pharmaceutical, viagra

Pfizer revealed in its briefing on its second quarter financials that Ibrance, its breast cancer treatment, had grown in sales …

News
anabella_villalobos

Biogen steal away Pfizer VP to boost R&D plans

August 1, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer has had a tough time keeping hold of its Vice President’s involved in R&D of late, losing high-profile researcher, …

Appointment
wood-1

GSK completes further high-profile staff acquisition

July 17, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer Senior Vice President of Medicinal Sciences, Tony Wood, has agreed to join GSK, as broken by FierceBiotech. The appointment …

Appointment
pounds_stacked

Regulators get aggressive on matters excessive

June 29, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CMA, Drug pricing, European Commission, Pfizer, aspen

Gustaf Duhs, Partner at Stevens & Bolton, discusses the recent cases of regulators becoming firmer with drug companies over their …

Feature

Pfizer’s biosimilar gets a second knock-back from FDA

June 23, 2017
Medical Communications, Sales and Marketing Amgen, Epogen, FDA, Pfizer

Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the …

News

Pfizer launches vaccine study in Group B Streptococcus

June 20, 2017
Manufacturing and Production, Research and Development Group B Streptococcus, Pfizer

A potentially pivotal Phase 1 study has been launched by Pfizer into the use of its investigational vaccine as a …

News
fda2outsideweb

FDA fast-tracks Pfizer and Lilly’s chronic pain drug

June 15, 2017
Research and Development, Sales and Marketing Eli Lilly, FDA, Pfizer

Pfizer and Eli Lilly are celebrating the FDA’s decision to grant fast-track designation to their joint venture tanezumab in the …

News
pfizer_sky

Pfizer gets fast-track approval for rare heart condition

June 8, 2017
Sales and Marketing Pfizer

Pfizer’s tafamidis has already been given approval in 40 countries across the globe but it has not currently broken into …

News
pfizer_finland_hq

Pfizer drug beats AZ rival in halting lung cancer

June 6, 2017
Manufacturing and Production, Research and Development NSCLC, Pfizer

New data from late-stage trials suggests that Pfizer’s dacomitinib beat out AstraZeneca’s rival treatment Iressa (gefitinib) at halting the progression …

News
baking-soda-768950_960_720

Shortage of medicine made of kitchen basics hits US

May 23, 2017
Manufacturing and Production Pfizer, Sodium bicarbonate

Do you have a pot of unused baking soda that sits at the back of the cupboard, forgotten? Well, hospitals …

News

70 patients sue Pfizer over arthritis drug risks

May 22, 2017
Sales and Marketing Pfizer, celebrex

Pfizer has been hit with a £3.5 million lawsuit by 70 Scottish patients who claim that the use of its …

News

Sangamo secures FDA’s Fast Track Designation for haemophilia candidate

May 17, 2017
Research and Development, Sales and Marketing FDA, Pfizer, Sangamo Therapeutics

Sangamo Therapeutics has announced that the FDA has granted its cDNA gene therapy candidate for haemophilia A Fast Track Designation. …

News

India to immunise five million using Pfizer pneumococcal disease vaccine

May 15, 2017
Sales and Marketing 13-valent Pneumococcal Conjugate Vaccine, India, PCV 13, Pfizer

An Indian immunisation programme will make use of Pfizer’s 13-valent Pneumococcal Conjugate Vaccine (PCV 13) to treat around 5.15 million, …

News

Pfizer offers breast cancer drug for free following NICE rejection

May 5, 2017
Medical Communications, Sales and Marketing NICE, Pfizer

Following NICE’s decision rejecting Pfizer’s breast cancer therapy Ibrance (palbociclib) for use on the NHS, the manufacturer has announced that …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026